QiC Diabetes
Quality in Care (QiC) Diabetes recognises, rewards and shares innovative practice demonstrating quality in diabetes management, education and services for people with diabetes and/or their families, throughout the UK.
Gaining QiC recognition means an initiative has been highlighted by the NHS, patients and industry as improving the quality of life for people living with diabetes.
There are over 4 million people in the UK diagnosed with diabetes and an estimated 549,000 people undiagnosed with Type 2 diabetes. Its chronic nature means it is an increasing social and economic burden in the country and better, more efficient methods of care are necessary.
Dr Partha Kar - Associate National Clinical Director of Diabetes, NHS England
Bob Swindell - Trustee, Diabetes UK
The Awards
QiC Diabetes aims to recognise, reward and share innovative practice demonstrating quality in diabetes management, education and services for people with diabetes and/or their families.
It highlights the benefits and adaptability of entrants' initiatives to a wider healthcare audience, including presenting at the annual Diabetes UK Professional Conference. Further dissemination opportunities include webinars, newsletters, workshops and the communication channels of QiC Diabetes partner Sanofi and our programme supporters.
Entries are invited from anyone working in the diabetes arena in the UK and Ireland. Whatever the area of patient care and/or diabetes service delivery, if your initiative or programme relates to diabetes in any way, you should enter. Judges are keen to review a wide spectrum of entries and to recognise the innovative practice that we know is out there.
Now in its seventh year, Quality in Care Diabetes helps to identify innovations and innovators, recognise their achievements and disseminate their innovative practice more widely across the NHS, charities and industry for the ultimate benefi t of people with diabetes and/or their families and carers.
A Quality in Care award means an initiative has been recognised by the NHS, patients and industry as improving the quality of life for people living with diabetes.
Supporters
The programme is partnered by Sanofi and supported by the Association of British Clinical Diabetologists (ABCD), The Association of Children’s Diabetes Clinicians (ACDC),
Children and Young People's Diabetes Network (CYPDN)
, the Diabetes Inpatient Specialist Nurse (DISN) UK Group, Diabetes Research & Wellness Foundation (DRWF), Diabetes UK,
JDRF the type 1 diabetes charity, Primary Care Diabetes Society (PCDS), Training Research and Education for Nurses in Diabetes (TREND), Young Diabetologists and Endocrinologists' Forum (YDEF)
and the United Kingdom Clinical Pharmacy Association (UKCPA).
What people think of QiC Diabetes
"Diabetes UK is once again delighted to be able to collaborate on these important awards. They highlight and promote the exciting and innovative approaches that are being implemented around the UK to improve the care of people with diabetes."
Simon O'Neill, Director of Health Intelligence and Professional Liaison, Diabetes UK
"I have really enjoyed educating patients, healthcare professionals and the public about diabetes throughout my career so far. To have my contribution formally acknowledged by receiving the Outstanding Educator award from the Quality in Care programme is truly humbling. I will continue to build on the diabetes education focus that my team and I have developed over the last few years."
Dr Mayank Patel, Consultant in Diabetes University Hospital Southampton, Honorary Senior Clinical Lecturer (University of Southampton) and winner of Outstanding Educator at QiC Diabetes 2015
"Sanofi is pleased to support the QiC Programme in 2019 and to recognise those individuals, teams, Trusts and partnerships who demonstrate quality in care for people living with diabetes. We’re keen to see evidence of quality improvement which aligns with current NHS priorities. These include reducing variation in access and quality of care to minimise risk of complications, improving achievement of NICE treatment targets, expanding provision of structured education including digital self-management tools and ensuring hospitals provide access to multidisciplinary teams to improve recovery, reduce length of stays and future admission rates."
Professor Mike Baxter, Diabetes Therapy Lead, Sanofi Medical